Partnership
We are proud to announce that we have secured a strong strategic partner with the Interpath Laboratory, Inc from Oregon, USA, which is investing €250,000 in RobotDreams® as a first step, in addition to providing technical support. In addition, Interpath secures the option to increase its share in our disruptive StartUp before the end of the year with a further investment of €2.25 million €.
With Interpath Laboratory, we have won an independent full-service medical laboratory company from the USA, which will accelerate us in the blood test-based development of the first software module for AI-supported diagnosis of acute coronary syndrome (heart attack) and will also support us in market entry and medical approval in the USA, as well as in international expansion in the long term.
With this amount, we will continue to fund the product development phase, which includes medical studies in collaboration with the Medizinische Universität Graz.
About Interpath Laboratory:
Founded in 1967 and headquartered in Pendleton, Oregon, Interpath's three healthcare companies employ more than 1,200 people, including laboratory technicians, medical technologists, IT specialists, physicians and human resources staff as well as drivers who collectively travel 10,000 miles each day collecting and delivering specimens. Interpath uses the latest technology in instrumentation and has developed fully automated lines for the most efficient flow of specimens.
Under the partnership Interpath will provide the data as well as offering its expertise in laboratory diagnostics and the laboratory infrastructure to provide an important foundation for the successful development and launch of the software in the U.S. market.